IMMX

Conviction 77HealthcareScan · Mon, Aug 10, 2026

Bullish harami

IMMX$10.15+4.42%

ResistanceSupportVol 14

Vol MA14 1.97M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Immix Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.immixbio.com ↗

Price10.15

Change+4.42%

Gap+1.39%

Rel volume4.20×

Avg volume1.94M

Avg $ vol18.09M

SMA 209.30

SMA 509.39

SMA 2007.60

Price vs 50+8.15%

Price vs 200+33.48%

MA stackbullish

50/200 cross—

Supertrenddown · 10.29

RSI (14)57

MACD hist0.14

MACD crossbull · 2d

Stoch %K / %D94 / 89

ADX (14)21

+DI / −DI22 / 18

RSI divergence—

MACD divergence—

ATR %+7.34%

ADR %7.56%

52w high12.02

52w low1.96

From 52w high-15.56%

Above 52w low+417.86%

New 52w highNo

SqueezeOff

Bollinger width33.74%

%B0.77

Donchian pos71.48%

Donchian high11.08

Donchian low7.83

AVWAP (52w high)9.75

vs AVWAP high+4.07%

AVWAP (52w low)7.79

vs AVWAP low+30.33%

OBV trendFlat

Chaikin MF (20)-0.01

Today vs 20d4.20×

Avg vol (14d)1.97M

Avg vol (20d)1.94M

Avg $ vol (20d)18.09M

Market cap—

RS 3m (vs SPY)-3.81%

RS 6m (vs SPY)+49.25%

RS line new highNo

Trend template7/8

Technical rank78.3

1 week+20.55%

1 month-8.64%

3 months+4.10%

6 months+50.59%

1 year+324.69%

YTD+86.92%

P/E-23.61

P/B3.04

P/S34.75

P/FCF-28.18

EPS-0.8900

Div yield—

ROE-12.86%

ROA-12.31%

Debt/Eq—

Current25.13

EV/EBITDA—

Gross margin—

Net margin-147.19%

Rev growth—

EPS growth-36.21%

Price target20.40

Target upside109.98%

Analyst ratingBuy

Institutional47.83%

Ent. value469.51M

Revenue20M

Net income-11.56M

Gross profit—

Free cash flow-24.66M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out54.41M

Employees21

ListedThu, Dec 16, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction77 / 100

Pattern quality—

Tech rank78.3 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMMX

All disclosures →

No recent disclosed trades by Congress in IMMX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMMX · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Adams Helen C. Director · Common Stock · 2026-05-22	Grant	6.25K	$0	2026-05-22	2026-05-29
Chudnovsky Yekaterina Director · Common Stock · 2026-05-22	Grant	6.25K	$0	2026-05-22	2026-05-29
Ng Carey Director · Common Stock · 2026-05-22	Other	—	—	2026-05-22	2026-05-29
Hsu Jason Director · Stock Option (Right to Buy) · 2026-05-22	Grant	12.5K	$0	2026-05-22	2026-05-29
Marquet Magda Director · Stock Option (Right to Buy) · 2026-05-22	Grant	12.5K	$0	2026-05-22	2026-05-29
BUCHAN JANE Director · Stock Option (Right to Buy) · 2026-05-22	Grant	12.5K	$0	2026-05-22	2026-05-29
CHANG NANCY T Director · Common Stock · 2026-05-22	Other	—	—	2026-05-22	2026-05-29
Hsu Jason Director · Common Stock · 2026-05-22	Other	—	—	2026-05-22	2026-05-29
Hsu Jason Director · Common Stock · 2026-05-22	Grant	6.25K	$0	2026-05-22	2026-05-29
Rachman Ilya M CEO and Chairman · Stock Option (Right to Buy) · 2026-05-22	Grant	500K	$0	2026-05-22	2026-05-29

SEC filings

EDGAR filings in IMMX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.